![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SP100 | Human | (-)-alpha-phellandrene | increases expression | EXP | | 6480464 | alpha phellandrene results in increased expression of SP100 mRNA | CTD | PMID:25075043 | SP100 | Human | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of SP100 mRNA | CTD | PMID:23649840 | SP100 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SP100 mRNA | CTD | PMID:22079256 | SP100 | Human | 1,2-dichloroethane | decreases expression | ISO | RGD:1558598 | 6480464 | ethylene dichloride results in decreased expression of SP140 mRNA | CTD | PMID:28960355 | SP100 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SP100 mRNA | CTD | PMID:19619570 | SP100 | Human | 17beta-estradiol | decreases expression | ISO | RGD:1558598 | 6480464 | Estradiol results in decreased expression of SP100 mRNA; Estradiol results in decreased expression of SP140 more ... | CTD | PMID:39298647 | SP100 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SP100 mRNA | CTD | PMID:19619570|PMID:21185374 | SP100 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | RGD:1558598 | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of SP100 mRNA | CTD | PMID:31388691 | SP100 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SP100 mRNA | CTD | PMID:19619570 | SP100 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1558598 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SP100 mRNA; Tetrachlorodibenzodioxin results in increased expression of SP140 more ... | CTD | PMID:37172768 | SP100 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1558598 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SP100 mRNA | CTD | PMID:21570461 | SP100 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SP100 mRNA | CTD | PMID:16704738|PMID:20106945|PMID:21632981 | SP100 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SP100 mRNA | CTD | PMID:19619570 | SP100 | Human | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | RGD:1359550 | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in increased expression of SP100 mRNA | CTD | PMID:32109520 | SP100 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | EXP | | 6480464 | 2,2',4,4',5-brominated diphenyl ether results in increased expression of SP100 mRNA | CTD | PMID:26705709 | SP100 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of SP100 mRNA | CTD | PMID:37199045 | SP100 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | SP100 | Human | 3-methylcholanthrene | decreases expression | ISO | RGD:1558598 | 6480464 | Methylcholanthrene results in decreased expression of SP140 mRNA | CTD | PMID:25926378 | SP100 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1558598 | 6480464 | bisphenol S results in decreased expression of SP140 mRNA | CTD | PMID:33297965|PMID:39298647 | SP100 | Human | 4,4'-sulfonyldiphenol | affects expression | ISO | RGD:1558598 | 6480464 | bisphenol S affects the expression of SP100 mRNA | CTD | PMID:39298647 | SP100 | Human | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1558598 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of SP100 mRNA | CTD | PMID:19191707 | SP100 | Human | acetamide | increases expression | ISO | RGD:1359550 | 6480464 | acetamide results in increased expression of SP100 mRNA | CTD | PMID:31881176 | SP100 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SP100 mRNA | CTD | PMID:33167477 | SP100 | Human | alpha-phellandrene | increases expression | EXP | | 6480464 | alpha phellandrene results in increased expression of SP100 mRNA | CTD | PMID:25075043 | SP100 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of SP100 gene | CTD | PMID:25304211 | SP100 | Human | arsane | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | SP100 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of SP100 gene | CTD | PMID:25304211 | SP100 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | SP100 | Human | benzo[a]pyrene | decreases expression | ISO | RGD:1558598 | 6480464 | Benzo(a)pyrene results in decreased expression of SP100 mRNA | CTD | PMID:20713471|PMID:21569818 | SP100 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1558598 | 6480464 | Diethylhexyl Phthalate results in increased expression of SP100 mRNA | CTD | PMID:28085963 | SP100 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1558598 | 6480464 | Diethylhexyl Phthalate results in decreased expression of SP100 mRNA | CTD | PMID:34319233 | SP100 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SP100 mRNA | CTD | PMID:25047013 | SP100 | Human | bisphenol A | decreases expression | ISO | RGD:1558598 | 6480464 | bisphenol A results in decreased expression of SP100 mRNA | CTD | PMID:35598803 | SP100 | Human | bisphenol A | decreases expression | ISO | RGD:1359550 | 6480464 | bisphenol A results in decreased expression of SP100 mRNA | CTD | PMID:34947998 | SP100 | Human | bisphenol A | affects methylation | ISO | RGD:1558598 | 6480464 | bisphenol A affects the methylation of SP140 promoter | CTD | PMID:27334623 | SP100 | Human | bisphenol A | increases expression | ISO | RGD:1359550 | 6480464 | bisphenol A results in increased expression of SP100 mRNA | CTD | PMID:25181051 | SP100 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | SP100 | Human | bisphenol F | increases methylation | EXP | | 6480464 | bisphenol F results in increased methylation of SP100 gene | CTD | PMID:31601247 | SP100 | Human | bisphenol F | decreases expression | ISO | RGD:1558598 | 6480464 | bisphenol F results in decreased expression of SP100 mRNA | CTD | PMID:38685157 | SP100 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of SP100 protein | CTD | PMID:35688186 | SP100 | Human | carbon nanotube | increases expression | ISO | RGD:1558598 | 6480464 | Nanotubes, Carbon analog results in increased expression of SP100 mRNA; Nanotubes, Carbon analog results in more ... | CTD | PMID:25554681 | SP100 | Human | carbon nanotube | affects expression | ISO | RGD:1558598 | 6480464 | Nanotubes, Carbon affects the expression of SP140 mRNA | CTD | PMID:25554681 | SP100 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SP100 gene] | CTD | PMID:28238834 | SP100 | Human | chloroprene | decreases expression | ISO | RGD:1558598 | 6480464 | Chloroprene results in decreased expression of SP100 mRNA | CTD | PMID:23125180 | SP100 | Human | chromium(6+) | affects expression | ISO | RGD:1558598 | 6480464 | chromium hexavalent ion affects the expression of SP100 mRNA | CTD | PMID:28472532 | SP100 | Human | cisplatin | decreases response to substance | EXP | | 6480464 | SP100 protein results in decreased susceptibility to Cisplatin | CTD | PMID:16734730 | SP100 | Human | clofibrate | multiple interactions | ISO | RGD:1558598 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SP100 mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 | SP100 | Human | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of SP100 mRNA | CTD | PMID:19376846 | SP100 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SP100 mRNA | CTD | PMID:19549813 | SP100 | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of SP100 protein | CTD | PMID:35688186 | SP100 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SP100 mRNA | CTD | PMID:22147139 | SP100 | Human | deoxynivalenol | decreases phosphorylation | ISO | RGD:1558598 | 6480464 | deoxynivalenol results in decreased phosphorylation of SP100 protein | CTD | PMID:23811945 | SP100 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | SP100 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SP100 mRNA | CTD | PMID:37042841 | SP100 | Human | dimethylarsinic acid | multiple interactions | ISO | RGD:1558598 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | SP100 | Human | dioxygen | multiple interactions | ISO | RGD:1359550 | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression more ... | CTD | PMID:33729688 | SP100 | Human | diquat | decreases expression | ISO | RGD:1558598 | 6480464 | Diquat results in decreased expression of SP100 mRNA | CTD | PMID:36851058 | SP100 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SP100 mRNA | CTD | PMID:29803840 | SP100 | Human | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of SP100 mRNA | CTD | PMID:19244175 | SP100 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of SP100 mRNA | CTD | PMID:27188386 | SP100 | Human | folic acid | decreases expression | ISO | RGD:1558598 | 6480464 | Folic Acid results in decreased expression of SP140 mRNA | CTD | PMID:25629700 | SP100 | Human | geraniol | increases expression | EXP | | 6480464 | geraniol results in increased expression of SP100 mRNA | CTD | PMID:27683099 | SP100 | Human | gold atom | decreases expression | EXP | | 6480464 | Gold results in decreased expression of SP100 mRNA | CTD | PMID:25523186 | SP100 | Human | gold(0) | decreases expression | EXP | | 6480464 | Gold results in decreased expression of SP100 mRNA | CTD | PMID:25523186 | SP100 | Human | GSK-J4 | increases expression | EXP | | 6480464 | GSK-J4 results in increased expression of SP100 mRNA | CTD | PMID:29301935 | SP100 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | SP100 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of SP100 protein | CTD | PMID:32959892 | SP100 | Human | lead diacetate | decreases expression | ISO | RGD:1359550 | 6480464 | lead acetate results in decreased expression of SP100 mRNA | CTD | PMID:22641619 | SP100 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of SP100 protein | CTD | PMID:30501627 | SP100 | Human | manganese atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | SP100 | Human | manganese(0) | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | SP100 | Human | manganese(II) chloride | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | SP100 | Human | methamphetamine | increases expression | ISO | RGD:1558598 | 6480464 | Methamphetamine results in increased expression of SP100 mRNA | CTD | PMID:26307267 | SP100 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SP100 mRNA | CTD | PMID:23649840 | SP100 | Human | methylarsonic acid | multiple interactions | ISO | RGD:1558598 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | SP100 | Human | N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:1558598 | 6480464 | Ethylnitrosourea results in increased mutagenesis of SP140 intron | CTD | PMID:27776689 | SP100 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of SP100 mRNA | CTD | PMID:24768652|PMID:25583101 | SP100 | Human | nickel dichloride | decreases expression | EXP | | 6480464 | nickel chloride results in decreased expression of SP100 mRNA | CTD | PMID:21466819 | SP100 | Human | ozone | multiple interactions | ISO | RGD:1558598 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:34911549 | SP100 | Human | paracetamol | multiple interactions | ISO | RGD:1558598 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SP100 mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 | SP100 | Human | paracetamol | decreases expression | ISO | RGD:1359550 | 6480464 | Acetaminophen results in decreased expression of SP100 mRNA | CTD | PMID:33387578 | SP100 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SP100 mRNA | CTD | PMID:26690555 | SP100 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SP100 mRNA | CTD | PMID:21420995|PMID:29067470 | SP100 | Human | pentachlorophenol | increases expression | ISO | RGD:1558598 | 6480464 | Pentachlorophenol results in increased expression of SP100 mRNA | CTD | PMID:23892564 | SP100 | Human | perfluorohexanesulfonic acid | increases expression | ISO | RGD:1558598 | 6480464 | perfluorohexanesulfonic acid results in increased expression of SP100 mRNA | CTD | PMID:37995155 | SP100 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SP100 mRNA | CTD | PMID:22079256 | SP100 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SP100 mRNA | CTD | PMID:22079256 | SP100 | Human | propanal | decreases expression | EXP | | 6480464 | propionaldehyde results in decreased expression of SP100 mRNA | CTD | PMID:26079696 | SP100 | Human | quercetin | affects phosphorylation | EXP | | 6480464 | Quercetin affects the phosphorylation of SP100 protein | CTD | PMID:35688186 | SP100 | Human | resveratrol | multiple interactions | EXP | | 6480464 | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SP100 protein]]; more ... | CTD | PMID:19631782 | SP100 | Human | ruxolitinib | multiple interactions | EXP | | 6480464 | ruxolitinib inhibits the reaction [IFNB1 protein results in increased expression of SP100 mRNA] | CTD | PMID:28365849 | SP100 | Human | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of SP100 mRNA | CTD | PMID:19244175 | SP100 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of SP100 mRNA | CTD | PMID:25351596 | SP100 | Human | silver atom | increases expression | ISO | RGD:1558598 | 6480464 | Silver results in increased expression of SP140 mRNA | CTD | PMID:27131904 | SP100 | Human | silver(0) | increases expression | ISO | RGD:1558598 | 6480464 | Silver results in increased expression of SP140 mRNA | CTD | PMID:27131904 | SP100 | Human | sodium arsenate | multiple interactions | ISO | RGD:1558598 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | SP100 | Human | sodium arsenite | multiple interactions | ISO | RGD:1558598 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | SP100 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | SP100 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SP100 mRNA | CTD | PMID:38568856 | SP100 | Human | tert-butyl hydroperoxide | increases expression | ISO | RGD:1558598 | 6480464 | tert-Butylhydroperoxide results in increased expression of SP100 mRNA | CTD | PMID:14729362|PMID:15003993 | SP100 | Human | tetrachloromethane | affects expression | ISO | RGD:1558598 | 6480464 | Carbon Tetrachloride affects the expression of SP100 mRNA | CTD | PMID:17484886 | SP100 | Human | thioacetamide | increases expression | ISO | RGD:1359550 | 6480464 | Thioacetamide results in increased expression of SP100 mRNA | CTD | PMID:34492290 | SP100 | Human | titanium dioxide | increases expression | ISO | RGD:1558598 | 6480464 | titanium dioxide results in increased expression of SP100 mRNA | CTD | PMID:23557971 | SP100 | Human | trichloroethene | decreases expression | ISO | RGD:1359550 | 6480464 | Trichloroethylene results in decreased expression of SP100 mRNA | CTD | PMID:33387578 | SP100 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of SP100 mRNA | CTD | PMID:30510588 | SP100 | Human | triptonide | increases expression | ISO | RGD:1558598 | 6480464 | triptonide results in increased expression of SP100 mRNA | CTD | PMID:33045310 | SP100 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SP100 mRNA | CTD | PMID:28001369 | SP100 | Human | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of SP100 mRNA | CTD | PMID:23649840 | SP100 | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of SP100 mRNA | CTD | PMID:19244175 | SP100 | Human | vorinostat | multiple interactions | EXP | | 6480464 | vorinostat promotes the reaction [PML protein binds to SP100 protein] | CTD | PMID:19631782 | SP100 | Human | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of SP100 mRNA | CTD | PMID:27188386 | |